REFERENCES
- Campochiaro P A. Pathogenesis of proliferative vitreoretinopathy. Retina, D H Ogden, A P Schachat, R P Murphy, B M Glaser, S J Ryan. C.V. Mosby, London 2001; Vol. 3: 2221–2227
- Eibl K H, Kook D, Priglinger S, et al. Inhibition of human retinal pigment epithelial cell attachment, spreading, and migration by alkylphosphocholines. Investigative Ophthalmology & Visual Science. 2006; 47: 364–370
- Blankenship G W. Evaluation of a single intravitreal injection of 5-fluorouracil in vitrectomy cases. Graefe's archive for clinical and experimental ophthalmology 1989; 227: 565–568
- Khawly J A, Saloupis P, Hatchell D L, Machemer R. Daunorubicin treatment in a refined experimental model of proliferative vitreoretinopathy. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 1991; 229: 464–467
- Araiz J J, Refojo M F, Arroyo M H, Leong F L, Albert D M, Tolentino F I. Antiproliferative effect of retinoic acid in intravitreous silicone oil in an animal model of proliferative vitreoretinopathy. Investigative Ophthalmology & Visual Science. 1993; 34: 522–530
- Lee J J, Park J K, Kim Y T, et al. Effect of 2′-benzoyl-oxycinnamaldehyde on RPE cells in vitro and in an experimental proliferative vitreoretinopathy model. Investigative Ophthalmology & Visual Science. 2002; 43: 3117–3124
- Eibl K H, Banas B, Schoenfeld C L, et al. Alkylphosphocholines inhibit proliferation of human retinal pigment epithelial cells. Investigative Ophthalmology & Visual Science. 2003; 44: 3556–3561
- Bumcrot D, Manoharan M, Koteliansky V, Sah D W. RNAi therapeutics: a potential new class of pharmaceutical drugs. Nature Chemical Biology. 2006; 2: 711–719
- Rao R D, Buckner J C, Sarkaria J N. Mammalian target of rapamycin (mTOR) inhibitors as anti-cancer agents. Current Cancer Drug Targets. 2004; 4: 621–635
- Rhoads J M, Niu X, Odle J, Graves L M. Role of mTOR signaling in intestinal cell migration. American Journal of Physiology 2006; 291: G510–517
- Kwon Y S, Hong H S, Kim J C, Shin J S, Son Y. Inhibitory effect of rapamycin on corneal neovascularization in vitro and in vivo. Investigative Ophthalmology & Visual Science. 2005; 46: 454–460
- Zhang L, Li X, Zhao M, et al. Antisense oligonucleotide targeting c-fos mRNA limits retinal pigment epithelial cell proliferation: a key step in the progression of proliferative vitreoretinopathy. Experimental Eye Research. 2006; 83: 1405–1411
- Fastenberg D M, Diddie K R, Sorgente N, Ryan S J. A comparison of different cellular inocula in an experimental model of massive periretinal proliferation. American Journal of Ophthalmology. 1982; 93: 559–564
- Davis A A, Bernstein P S, Bok D, Turner J, Nachtigal M, Hunt R C. A human retinal pigment epithelial cell line that retains epithelial characteristics after prolonged culture. Investigative Ophthalmology & Visual Science. 1995; 36: 955–964
- Kristof A S, Marks-Konczalik J, Billings E, Moss J. Stimulation of signal transducer and activator of transcription-1 (STAT1)-dependent gene transcription by lipopolysaccharide and interferon-gamma is regulated by mammalian target of rapamycin. The Journal of Biological Chemistry. 2003; 278: 33637–33644
- Hsieh A C, Bo R, Manola J, et al. A library of siRNA duplexes targeting the phosphoinositide 3-kinase pathway: determinants of gene silencing for use in cell-based screens. Nucleic Acids Research. 2004; 32: 893–901
- Shegogue D, Trojanowska M. Mammalian target of rapamycin positively regulates collagen type I production via a phosphatidylinositol 3-kinase-independent pathway. The Journal of Biological Chemistry. 2004; 279: 23166–23175
- Chiu M I, Katz H, Berlin V. RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex. Proceedings of the National Academy of Sciences of the United States of America 1994; 91: 12574–12578
- Costa L J. Aspects of mTOR biology and the use of mTOR inhibitors in non-Hodgkin's lymphoma. Cancer Treatment Reviews. 2007; 33: 78–84
- Hosoi H, Dilling M B, Shikata T, et al. Rapamycin causes poorly reversible inhibition of mTOR and induces p53-independent apoptosis in human rhabdomyosarcoma cells. Cancer Research 1999; 59: 886–894
- Jin M, He S, Worpel V, Ryan S J, Hinton D R. Promotion of adhesion and migration of RPE cells to provisional extracellular matrices by TNF-alpha. Investigative Ophthalmology & Visual Science. 2000; 41: 4324–4332
- Shen J, Samul R, Silva R L, et al. Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1. Gene Therapy 2006; 13: 225–234